Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 685s Year: 2005
The role of cardio pulmonary exercise testing (CPET) in patients with cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009
Pulmonary function, inflammation, exercise capacity and quality of life in cystic fibrosis Source: Eur Respir J 2001; 17: 712-715 Year: 2001
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis Source: Eur Respir J 2012; 40: 61-66 Year: 2012
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI) Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology Year: 2014
Impact of sensitization to Aspergillus fumigatus on lung function in cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010
Long-term effects of a partially supervised conditioning programme in cystic fibrosis Source: Eur Respir J 2010; 35: 578-583 Year: 2010
Effects of flow-dependent and threshold PEP on lung functions in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 332s Year: 2003
Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Improved survival at low lung function in cystic fibrosis (CF) Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009
Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013
Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Progression of lung involvement in patients with cystic fibrosis (CF), assessed by longitudinal respiratory function measurements Source: Eur Respir J 2002; 20: Suppl. 38, 20s Year: 2002
Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012
Changes in ventilatory mechanics with increasing disease severity in children and adolesecents with cystic fibrosis (CF) Source: Eur Respir J 2002; 20: Suppl. 38, 209s Year: 2002
Dynamic hyperinflation causes exercise limitation in patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
PP309 – Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: ERS Lung Science Conference 2021 Year: 2021
Effect of noninvasive ventilation on functional exercise capacity, lung funtion and compartmental chest Wall volume in children With cystic fibrosis Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases Year: 2018